Lithium Dosing Recommendations
Initial Dosing for Acute Mania
For acute mania, start lithium carbonate at 600 mg three times daily (1800 mg/day total), targeting serum levels of 1.0-1.5 mEq/L, with dose adjustments based on twice-weekly serum level monitoring until stabilization. 1
- The FDA-approved starting regimen is 600 mg three times daily, which typically produces effective therapeutic serum concentrations between 1.0-1.5 mEq/L 1
- For elderly patients, reduce the starting dose substantially to 150 mg/day due to increased sensitivity and reduced clearance 2
- Patients weighing less than 62 kg or those with renal impairment require lower initial doses 3
Maintenance Dosing for Long-Term Control
Maintenance therapy should target serum levels of 0.8-1.0 mEq/L using 300 mg three to four times daily (1200-1600 mg/day), as this range provides superior relapse prevention compared to lower levels. 1, 4
- The FDA recommends 300 mg three to four times daily for maintenance, targeting serum levels of 0.6-1.2 mEq/L 1
- However, the most rigorous evidence from a randomized controlled trial demonstrates that maintaining levels at 0.8-1.0 mEq/L reduces relapse risk by 2.6-fold compared to levels of 0.4-0.6 mEq/L, despite increased side effects 4
- Age-based dosing guidelines: patients under 40 years typically require 925-1300 mg daily; ages 40-60 require 740-925 mg daily; over 60 years require 550-740 mg daily 5
Dosing Schedule Considerations
Once-daily evening dosing is equally effective as divided dosing and produces fewer renal side effects, making it the preferred administration schedule for most patients. 6
- Once-daily dosing significantly reduces urinary frequency compared to twice-daily dosing (p=0.008 at Day 21, p=0.035 at Day 42) while maintaining equivalent efficacy 6
- Once-daily dosing requires lower total daily doses and produces more stable serum levels 6
- If using sustained-release formulations with once-daily dosing, target the upper therapeutic range (0.8-1.0 mEq/L) rather than 0.6-0.8 mEq/L to compensate for delayed peak concentrations 5
Monitoring Requirements During Dose Titration
Check serum lithium levels twice weekly during acute treatment and after any dose adjustment until levels and clinical status stabilize. 1, 2
- Draw blood samples 8-12 hours after the previous dose (trough levels) for standard formulations 1
- For once-daily dosing, draw levels at 24 hours post-dose 5
- During maintenance, monitor levels every 2 months in stable patients 1
- Increase monitoring frequency to 1-2 weeks after dose changes, addition of interacting medications, changes in renal function, or significant weight changes 7
Renal Impairment Adjustments
Reduce lithium dose by 50% in patients with GFR <30 mL/min/1.73 m², and consider lower doses with more frequent monitoring when GFR is 30-60 mL/min/1.73 m². 2
- Significant renal impairment (GFR <30 mL/min/1.73 m²) requires 50% dose reduction 2
- Moderate renal impairment (GFR 30-60 mL/min/1.73 m²) requires lower doses and more frequent monitoring than the standard 2-month interval 2, 7
- Lithium clearance decreases with aging, necessitating dose reductions in elderly patients who may exhibit toxicity at levels ordinarily tolerated by younger patients 1
Baseline Laboratory Requirements
Before initiating lithium, obtain complete blood count, thyroid function tests (TSH, free T4), renal function (BUN, creatinine, GFR), serum electrolytes including calcium, and urinalysis. 2
- These baseline tests identify contraindications including significant renal impairment, cardiovascular disease, severe dehydration, and sodium depletion 2
- During maintenance, monitor thyroid function tests, weight, and blood pressure annually 7
Critical Dosing Pitfalls
- Never rely solely on serum levels—accurate evaluation requires both clinical assessment and laboratory analysis 1
- Avoid NSAIDs as they increase lithium levels and toxicity risk 2
- Toxicity can occur at doses close to therapeutic levels, with serious toxicity beginning at serum levels >2.0 mEq/L 2
- Maintain adequate hydration, especially during intercurrent illness, as dehydration rapidly increases lithium levels 2
- During pregnancy, lithium clearance increases 30-50% in the last trimester, requiring dose increases to maintain therapeutic levels 5